Jonathan Krinsky, chief market technician at BTIG, joins CNBC's 'The Exchange to discuss his outlook on stocks for 2025, what ...

In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Glaukos (GKOS – Research Report), with a price target of ...

In a report released today, Thomas Shrader from BTIG maintained a Buy rating on Denali Therapeutics (DNLI – Research Report), with a price ...

The S&P 500's rally of 1.8% over just the last two sessions is nice, "but not a game changer yet," according to BTIG's technical guru, Jonathan Krinsky. The chart he provides, below, shows the stock ...

BTIG Research has recently reduced Fiverr International Ltd (FVRR) stock to Neutral rating, as announced on November 4, 2024, according to Finviz. Earlier, on July 2, 2024, UBS had reduced the stock ...

Ten-year Treasury yields were hovering just shy of their highest since last May, and the 30-year yield was close to its ...

Zoetis Inc (ZTS) stock saw a modest uptick, ending the day at $165.9 which represents a slight increase of $2.59 or 1.59% from the prior close of $163.31. The stock opened at $162.77 and touched a low ...

BTIG's Krinsky noted that while equity markets in the first half of 2024 were fueled mostly by the surge in mega-cap names ...

Here are four large-cap value stocks that growth and income investors may want to consider now. History suggests they could rally this year.

McDonald's ( MCD) is paving the way for more value competition in 2025 with its new McValue platform. Bernstein analyst Danilo Gargiulo called its first national value offering since 2018 a ...

BTIG lowered the firm’s price target on Staar Surgical (STAA) to $39 from $49 and keeps a Buy rating on the shares as part of ...

BTIG raised the firm’s price target on Glaukos (GKOS) to $157 from $149 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models on Medical Technology names ...